// App-Quantinova.ai

PO‐138 : Efficacy and tolerability of first line steroid treatment in patients with immune thrombocytopenic purpura (ITP); real world data from a single centre

Researchers

Presenter

  • L Carter-Brzezinski

Principal Investigators

  • R Greenwood

  • L Hunphrey

  • C Bradbury

Medical Centers

  • Research & Innovation, UH Bristol NHS Foundation trust

  • Department of Haematology, Bristol Haematology and Oncology Centre

  • Bristol Childrens Vaccine Centre Schools of Clinical Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisolone

  • Romiplostim

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved